Purpose: The pro-inflammatory effects of kinins are mediated by two bradykinin receptors: BR1 and BR2. The aim of this study was to evaluate the expression profile of kinin receptor genes by an estimation of mRNA levels in human nasal polyps (NP) and normal mucosa (NM). Material and Methods: BR1 and BR2-dependent genes differentially transcribed in NP were investigated using oligonucleotide microarray technology. The mRNA copy number of BR1, BR2 and TIMP1 genes was assessed by QRT-PCR. Thirty six eosinophilic (ENP), 17 neutrophilic nasal polyps (NNP) and 28 NM samples were included into the study. Results: Among 92 genes encoding proteins involved in signal transduction via B1 and B2 kinin receptors TIMP1 was found to be 2,63-fold higher in the NP than in NM. Increased TIMP1 gene expression was proved by QRT-PCR (p=0,003). Moreover two genes: FOS and PTGS1 presented higher (3,82-and 4,27-fold, respectively) expression in NM compared to NP tissues. In QRT-PCR analysis insignificantly higher expression of gene encoding BR1 in ENP [2564 mRNA copies/μg RNA (22-32863)] compared with NM [1426 copies mRNA (15-27995)] was found. mRNA expression for the BR2 in ENP [9872 copies mRNA (19-244832)] was insignificantly higher than in NM [5753 copies (46-199658)]. BR2 mRNA was the predominant transcript in most NP and NM samples followed by BR1 mRNA (p<0,01). There was a positive correlation between the expression of BR1 and BR2 in the ENP (r=0,91; p<0,01) and NNP (r=0, 6; p<0,01).
INTRODUCTION
Although the pathogenesis of nasal polyps (NP) is not fully understood, the disease is considered to be a chronic inflammation process of complex character [1] . NP formation is regulated through the release of a wide spectrum of inflammatory mediators and cytokines. The activation of the kallikrein-kininogen cascade generating the kinin peptides may be a part of this process. Kinins belong to the group of 9-11 amino acid peptides including bradykinin (BK), kallidin, T-kinin and their active metabolites, e.g. des-Arg9-kinins. They are important mediators produced in blood and tissues like nasal epithelium and are involved in both the initiation and progression of an inflammatory response. Kinins exert their biological effects through the activation of two receptors, denoted as subtypes B1 and B2. Both belong to the superfamily of seven-transmembrane G-protein coupled receptors [2] . Activation of the kinin receptors modulates release of a variety of proinflammatory mediators such as: eikozanoids, histamine, platelet-activating factor (PAF), interleucine 1 (IL-1), tumor necrosis factor (TNF), serotonin and enhanced NO synthesis [3] . In such a signal transduction pathway many genes encoding kinin-dependent proteins [i.e. prostaglandin-endoperoxide synthase (PTGS), FOS, RASs, tissue inhibitors of matrix metalloproteinase (TIMPs) and others] could be involved. The expression of B1 receptors (BR1) is tightly regulated and physiologically absent or at very low level in normal tissue. In response to pathophysiological processes like tissue inflammation or damage, BR1 expression can be unregulated [4] [5] [6] [7] . Thus, B1 receptors may be candidate as therapeutic targets upstream in the cascade in airway inflammation. In contrast, kinin B2 receptor (BR2) is expressed constitutively in many cell types under normal conditions.
The induction of bradykinin receptors has been strongly linked to inflammatory pathologies including chronic bronchial asthma or allergic rhinitis [8] . Although it is quite well-recognized that kinin receptors play an important role in the process of human airway inflammation [9] , their potential role in nasal polyp formation is unknown.
The aim of the current study was to compare the expression profile of kinin receptors on the mRNA levels in human nasal polyps and normal controls. Oligonucleotide microarray technology was used to investigate the transcriptional activity of kinin-dependent genes in the nasal polyps.
MATERIAL AND METHODS

Subjects
Fifty-three patients (21 females and 32 males) with nasal polyps treated surgically at the Department of Otolaryngology, Wroclaw Medical University were included in the study. All the subjects met the diagnostic criteria for chronic rhinosinusitis as established by the Task Force on Rhinosinusitis (AAO-HNS) [10] . The patients' ages ranged from 12 to 82 years (mean 51,2 ± 15,2 years). The extent of the disease was assessed by CT and also endoscopically. Patients had been free of any medication for at least 4 weeks before surgery and had bilateral polyps in the nasal cavities on endoscopic examination. The presence of comorbidity or smoking history was also excluded. The control group consisted of 28 healthy persons (9 females and 19 males). The patients' ages ranged from 17 to 76 years (mean 36,4 ± 16,8 years) (Tab. 1). Absence of NP was assessed by clinical history, endoscopic examination and imaging. Prick tests were performed to rule out the existence of allergy. A history of other diseases was also excluded. Control tissue samples were taken from unchanged nasal mucosa of the lower turbinate during septoplasty.
For DNA microarray analysis 21 patients with NP (14 males and 7 females; mean age 50,82 ± 16,37 years) from the above group were included; the control samples were taken from 8 healthy people (6 males and 2 females; mean age 32,43 ± 13,29 years).
Nasal polyp specimens and control mucosae were immediately frozen in liquid nitrogen, and stored at -70 o C pending further investigations. A part of each sample was fixed in 10% buffered neutral formalin, processed routinely, and embedded in paraffin wax for subsequent immunohistochemical examination. The study was approved by the Local Ethical Committee of Wroclaw Medical University.
Histological Examination
Serial sections of paraffin-embedded samples were stained with hematoxylin-eosin to visualize inflammatory cells and to exclude other pathologies. Five visual fields per section were examined to calculate the mean percentage of eosinophils out of the total inflammatory cells. NPs were classified as eosinophilic when eosinophils comprised more than 8.0% of inflammatory cells, and as neutrophilic when eosinophils comprised less than 8.0% of the inflammatory cells. Noneosinophilic polyps show characteristic counterparts including profound glandular hypertrophy, fibrosis, and the presence of lymphocytes, neutrophils, and plasma cells.
According to this criterion 36 (68%) cases were classified as eosinophilic and 17 (32%) as neutrophilic. Eleven patients with eosinophilc and 6 with neutrophilc NP were subjected to microarray analysis.
RNA extraction
Total RNA was extracted from frozen tissue specimens (about 40 mg) with the use of TRIzol ® reagent (Invitrogen, Carlsbad, CA) according to the producer's protocol. Tissues were homogenized in Trizol using a Tissues Homogenizer Polytron ® (Kinematyka AG, Switzerland). All RNA extracts were treated with DNA-se I and cleaned with a Mini-spin column using an Rneasy Mini Total RNA Purification kit (Qiagen, Valencia, CA).
The RNA extracts were qualitatively checked by electrophoresis in 1,0% agarose gel stained with ethidium bromide. RNA concentration was determined on the basis of absorbance values at a wavelength of 260 nm using a GeneQuant pro (Biochrom, Cambridge, UK). that correspond to more than 18400 transcripts and 14500 well-characterized human genes. About 8 μg of total RNA were used for the cDNA synthesis using SuperScript Choice System (Gibco BRL Life Technologies). In the next step, cDNA were used as a template to produce biotin-labeled cRNA using BioArray HighYield RNA Transcript Labeling Kit (Enzo Life Sciences). cRNA was purified on Rneasy Mini Kit columns (Qiagen). Next, the biotin-labeled cRNA were fragmented using Sample Cleanup Module (Qiagen) and hybridized with the HG-U133A microarray (Affymetrix). The hybridized cRNA probes to oligonucleotide arrays were stained with streptavidin-phycoerythrin conjugate and were scanned using GeneArray Scanner G2500A. The scanned data were processed for signal values using Microarray Suite 5.0 software (Affymetrix). The results obtained were normalized using RMAExpress software.
Microarray procedure
Real-time quantitative RT-PCR
Transcriptional activity of BR1, BR2 and TIMP1 genes was identified by the use of real-time QRT-PCR technique with a SYBR Green I chemistry (SYBR Green Quantitect RT-PCR Kit, Qiagen, Valencia, CA, USA). Analysis was carried out using an Opticon™ DNA Engine Sequence Detector (MJ Research, USA). Primers for BR1, BR2 and TIMP1 were designed using Primer Express 1.0 software (PE Applied Biosystems, USA) (Tab. 2). Oligonucleotide primers specific for mRNAs BR1 and BR2 were described previously [11] . The thermal conditions for one-step RT-PCR were as follows: 50˚C for 30 min for reverse transcription and 95˚C for 15 min, 50 cycles at 94˚C for 15 s, 60˚C for 30 s and 72˚C for 30 s. After completion of the cycle process, the samples were subjected to temperature ramp from 60 to 95˚C at a rate of 0,2˚C/s with continuous fluorescence monitoring from melting curve analysis. Glyceraldehydre-3-phosphate dehydrogenase (GAPDH), and β-actin were used as internal controls in each single QRT-PCR for all samples. All samples were analyzed in triplicate. Standards, from 400 to 8000 copies cDNA β-actin (TaqMan® DNA Template Reagents Kit, PE Applied Biosystems) were run alongside the samples to generate a standard curve. β-actin and GAPDH were used to monitor RT-PCR reaction and to exclude the presence of its inhibitors. The specifics of RT-PCR reaction was confirmed by determining characteristic temperature of melting for each amplimer. The
RT-PCR products were separated on 6% polyacrylamide (PAA) gels and visualized with silver salts.
Statistical analysis
Statistical analysis was performed with Statistica 6.0 software. The Mann-Whitney U and χ 2 tests were used in the comparison of age and sex between patients and the control groups. The regression analysis and the t test for the two unpaired group were used in microarray data analysis. The differences between polyps and normal mucosa tissues in the expression of examined genes, detected by real-time RT-PCR, were analyzed using the Wilcoxon and Mann-Whitney U tests. The Spearman rank correlation test was used to assess the relationship between mRNAs BR1 and BR2 level. The final results of mRNA copy number per μg of total RNA were expressed as medians and range. The significance level was assumed for p<0,05.
RESULTS
In the first stage of the study, BR1 and BR2 mRNAs expression by real-time QRT-PCR were determined. For each RT-PCR product, a single peak was performed by melting curve analysis at the expected temperatures (Fig. 1) . Additionally, the specificity of RT-PCR for the target genes was confirmed on the basis of PAA electrophoresis, which revealed the presence of single products of the predicted length (Fig. 2) . The BR1 and BR2 mRNAs were detected in all cases of both the study and the control group. The transcriptional activity of examined genes in NP and in controls was presented in Tab.3. BR2 mRNA was the predominant transcript in most NP and normal mucosa samples followed by BR1 mRNA (p<0,01; Wilcoxon test). A lower expression of BR1 was detected in the control group than in NP including eosinophilic nasal polyps, but these differences were not statistically significant (p>0,05; Mann-Whitney U test). B1 receptor gene expression in NNP was similar to control subjects (p=0,570). Expression of mRNA BR2 in NP and normal mucosa at a comparable level was found (p>0,05). Transcriptional activity of the BR2 gene in ENP was higher than in the controls, but not statistically significant (p=0,423). Reverse: 5'GCCACAAAACTGCAGGTAGTGATGT3' Table 2 . Characteristics of primers used for amplification.
bp -base pair; TM -temperature of melting A positive correlation between the BR1 and BR2 mRNA expression in the ENP (r=0,91; p<0,01) and NNP (r=0,6; p<0,01) was identified.
In the next step of the research, genes showing various expressions in NPs in comparison with normal nasal tissues were identified by DNA microarray analysis. On the basis of the Affymetrix database (http://www.affymetrix.com/analysis/ index.affx) 92 genes encoding proteins involved in signal transduction via B1 and B2 kinin receptors were chosen. Genes were considered as potentially differencing if p<0,05 and there was at least a 2-fold change in the mean expression levels between NPs and the control tissues [12, 13] . Three genes were identified as having at least a 2-fold difference in expression between the groups (Fig. 3) . Gene encoding tissue inhibitor of matrix metalloproteinase-1 (TIMP1) was found to be expressed 2,63-fold higher in the NP compared with the control subjects. Two genes: FOS and PTGS1 (Prostaglandinendoperoxide synthase-1) presented higher (3,82-and 4,27-fold, respectively) expression in the controls compared with NP tissues. Gene encoding kallikrein 1 (KLK1) had also a higher (2,44-fold), but not significantly expression in the controls (Tab. 4). 
BR1 BR2 TIMP1
Nasal Subsequently, transcriptional activity of TIMP1 gene was confirmed by real-time QRT-PCR. The specificity of RT-PCR was experimentally proved (Fig. 1, 2) . Expression of TIMP1 mRNA was statistically higher in NPs than in normal mucosa (p=0,003) (Tab. 1). Comparative analysis of the copy number of TIMP1 mRNA revealed a higher expression in both NNP (p=0,027) and ENP (p=0,009) than in normal nasal tissues (Fig. 4) .
DISCUSSION
Kinin receptor genes expression profile was revealed to change in various pathological states. However, the role of kinin B1 receptors in humans is still controversial [14] . Here we present the observation that kinin B1 and B2 receptor expression can be not significantly different in NPs compared to the control group. Especially among eosinophilic NPs the mRNA copy number for BR1 and BR2 was revealed to be higher than in healthy mucosae.
In the control group both types of BK receptors were detected which contrasts with previous observations as the BR1 is generally absent or at a very low level in healthy tissues. Christiansen et al [8] observed mRNA of B1 receptor only in 18% of healthy nasal epithelia. They also demonstrated significantly higher expression of BR1 in allergic rhinitis subjects than in normal individuals. Similar to our data, they did not prove a substantial difference in BR2 expression between the groups examined. Due to the BR1 multicellular location and mode of persistent signaling mechanism, the receptor is likely to exert a strategic role particularly on SLR -signal log ratio between patient and control expression levels. Base 2 is used as the log scale, therefore a SLR of 1 indicates a 2-fold increase in the transcript level and 1 indicates a 2-fold decrease. a t-test; ↑ significantly higher expression in nasal polyps than in the control group; ↓ significantly lower expression in nasal polyps than in the control group inflammation with an immune etiology [15] . However, such an etiology rather does not underlie the cause of NPs. What is more, it has been reported in several studies that NP subjects present a lower incidence of allergic rhinitis [16] .
Bradykinin receptors mediate the opening of the tight junctions between endothelial cells causing increased vascular permeability, plasma exudation and edema. The BR1 is involved in most of the cardinal signs of inflammation [17] . It is induced and overexpressed in response to bacterial endotoxins and cytokines such as IL-1β, IL-2, IL-8, TNF-α and INF-γ [4] . Activation of BR1 has been demonstrated to stimulate cell proliferation and induce IL-1β and TNF-α releasing [18] [19] [20] . Moreover, inflammation cytokines like INF-γ, IL-1β and TNF-α may cause up-regulation of BR2 mRNA and protein in cells [21, 22] . These findings imply that a wide spectrum of cytokines connected with NP formation may inflict BK receptor expression and inversely.
Prolonged tissue inflammation is accompanied by an increased amount of active metabolites (des-Arg9-bradykinin and des-2 Arg10-kallidin), which induce BR1 expression [23] . In the main, a higher expression of BR1 seems to occur only during the chronic stages of inflammation, whereas BR2 is most likely seen in the acute phase of inflammation [24] . Within the group of NPs, kinin B1 receptor mRNA level increased more visibly than in the control subjects what complies with previous observations. Trifilieff et al. [25] suggest that the B2 receptor is the major kinin receptor involved in airway responses to kinins. Icatibant (HOE-140), a BR2 antagonist, removed hyperresponsiveness to histamine and reduced nasal eosinophilia induced by Ag in patients with allergic rhinitis [26] . Christiansen et al. [8] hypothesize that the kinin system contributes to the development of airway inflammation initially through the BR2, with subsequent up-regulation of the BR1. It could explain our data as we observed a higher level of mRNA BR2 than BR1 in most NPs and normal mucosae.
In ENP and NNP tissues a statistically significant correlation of both receptors was observed. This could be explained in part by coexpression of genes encoding B1 and B2 kinin receptors in nasal tissues.
It has been shown in recent studies that activation of the BK receptors leads to a number of intracellular events. Through the intracellular network of secondary transmitters, receptors of kinin B modulate various effectors. To gain further insight into the cellular mechanism following kinin B receptors induction, BR1 and BR2 dependent genes were investigated using oligonucleotide microarray technology. Microarrays are a high-throughput method, which allow the simultaneous evaluation of the expression of tens of thousands of genes. Moreover, this tool permits the identification of the new biological disease markers or drug targets and also pathogenetic mechanisms. Among genes 92 encoding proteins which take part in kinin signaling pathways only TIMP1 was revealed to be statistically more highly expressed in NP tissues compared to the controls. Also Liu et al. by the use of DNA microarrays determined TIMP1 as up-regulated gene in NPs compared to normal and sphenoid sinus mucosa [13] . The elevated TIMP1 level has been found previously in chronic rhinosinusitis and NPs [27] . Such observation confirms that the MMP/TIMP balance is, in principle, a critical factor in regulating the breakdown of connective tissues and non-matrix substrates by MMPs. Recent studies, however, have shown that MMP9 deficiency can promote airway inflammation [28] . TIMP1 as specific inhibitor was shown to have growth promoting activity in several cell types [29] . Excess of TIMP1 is supposed to be responsible for fibrosis airway in asthma [30] .
Prostaglandin-endoperoxide synthase-1 (PTGS-1) catalyzes the synthesis of prostaglandins G2 and H2. Moreover, it serves as the precursor for a number of important prostanoids including prostaglandin E2. PTGS-1 is constructively expressed and relatively unaffected by inflammatory mediators. It has been documented that the PTGS-1 is expressed in normal mucosa of upper respiratory tract and its expression is not subjected to change in NPs [31] . Our findings support the thesis that PTGS-1 may possibly play some role in chronic rhinosinusitis. However, the degree of commitment PTGS-1 in inflammatory reactions depends on the inflammatory stimulus and kind of tissue.
Activation of kinin B receptors leads to activation of FOS gene and finally to the formation of AP-1. AP-1 transcription factor participates in the induction of a wide variety of proinflammatory proteins, receptors and mediators. c-FOS mRNA has been previously detected in both NPs and normal nasal epithelium [32] . Our data agrees with earlier observations that fibroblasts, endothelium and inflammatory cells of NP show low c-FOS protein expression. This may suggest that c-FOS/AP-1 mediated processes are more important in the epithelium. The production of FOS by epithelial cells indicates a more integral role and mirrors sophisticated relations.
CONCLUSIONS
The current report for the first time demonstrates the expression pattern of kinin receptors genes and also kinin-dependent genes in nasal polyps. We did not identify changes in the expression profile of kinin receptors in analyzed groups, which suggests that kinin receptors may not make an important contribution to the etiology of nasal polyps. The potential role of genes encoding proteins involved in transduction signal via B1, B2 kinin receptors in inflammation processes and NP formation needs further investigation.
